{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:44:48Z","timestamp":1775155488835,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/s1474-4422(24)00052-8","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T19:41:30Z","timestamp":1710531690000},"page":"465-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Safety and efficacy of continuous subcutaneous levodopa\u2013carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial"],"prefix":"10.1016","volume":"23","author":[{"given":"Alberto J","family":"Espay","sequence":"first","affiliation":[]},{"given":"Fabrizio","family":"Stocchi","sequence":"additional","affiliation":[]},{"given":"Rajesh","family":"Pahwa","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Albanese","sequence":"additional","affiliation":[]},{"given":"Aaron","family":"Ellenbogen","sequence":"additional","affiliation":[]},{"given":"Joaquim J","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Nir","family":"Giladi","sequence":"additional","affiliation":[]},{"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[]},{"given":"Sharon","family":"Hassin-Baer","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Hernandez-Vara","sequence":"additional","affiliation":[]},{"given":"Stuart H","family":"Isaacson","sequence":"additional","affiliation":[]},{"given":"Karl","family":"Kieburtz","sequence":"additional","affiliation":[]},{"given":"Peter A","family":"LeWitt","sequence":"additional","affiliation":[]},{"given":"Lydia","family":"Lopez-Manzanares","sequence":"additional","affiliation":[]},{"given":"C Warren","family":"Olanow","sequence":"additional","affiliation":[]},{"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[]},{"given":"Harini","family":"Sarva","sequence":"additional","affiliation":[]},{"given":"Tami","family":"Yardeni","sequence":"additional","affiliation":[]},{"given":"Liat","family":"Adar","sequence":"additional","affiliation":[]},{"given":"Laurence","family":"Salin","sequence":"additional","affiliation":[]},{"given":"Nelson","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Nissim","family":"Sasson","sequence":"additional","affiliation":[]},{"given":"Ryan","family":"Case","sequence":"additional","affiliation":[]},{"given":"Olivier","family":"Rascol","sequence":"additional","affiliation":[]},{"given":"Mitra","family":"Afshari","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Alonso-Frech","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Amelin","sequence":"additional","affiliation":[]},{"given":"David","family":"Arkadir","sequence":"additional","affiliation":[]},{"given":"Samih","family":"Badarny","sequence":"additional","affiliation":[]},{"given":"Ernest","family":"Balaguer Martinez","sequence":"additional","affiliation":[]},{"given":"Marek","family":"Balaz","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Blazuez Estrada","sequence":"additional","affiliation":[]},{"given":"Andrzej","family":"Bogucki","sequence":"additional","affiliation":[]},{"given":"James","family":"Boyd","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Buyan Dent","sequence":"additional","affiliation":[]},{"given":"Camille","family":"Carroll","sequence":"additional","affiliation":[]},{"given":"Giovanni","family":"Castelnovo","sequence":"additional","affiliation":[]},{"given":"Martinez","family":"Castrillo","sequence":"additional","affiliation":[]},{"given":"K Ray","family":"Chaudhuri","sequence":"additional","affiliation":[]},{"given":"Jeffrey","family":"Cooney","sequence":"additional","affiliation":[]},{"given":"Anne-Ga\u00eblle","family":"Corbill\u00e9","sequence":"additional","affiliation":[]},{"given":"Esther","family":"Cubo Delgado","sequence":"additional","affiliation":[]},{"given":"Teodor","family":"Danaila","sequence":"additional","affiliation":[]},{"given":"Rob","family":"De Bie","sequence":"additional","affiliation":[]},{"given":"Joy Antonelle","family":"De Marcaida","sequence":"additional","affiliation":[]},{"given":"Maria Francesca","family":"De Pandis","sequence":"additional","affiliation":[]},{"given":"Sophie","family":"Dethy","sequence":"additional","affiliation":[]},{"given":"Rohit","family":"Dhall","sequence":"additional","affiliation":[]},{"given":"Ruth","family":"Djaldetti","sequence":"additional","affiliation":[]},{"given":"John","family":"Duda","sequence":"additional","affiliation":[]},{"given":"Franck","family":"Durif","sequence":"additional","affiliation":[]},{"given":"Borrue","family":"Fernandez","sequence":"additional","affiliation":[]},{"given":"Yeva","family":"Fernandez","sequence":"additional","affiliation":[]},{"given":"Stephen","family":"Flitman","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Freyre Alvarez","sequence":"additional","affiliation":[]},{"given":"Caroline","family":"Giordana","sequence":"additional","affiliation":[]},{"given":"John","family":"Goudreau","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Grandas Perez","sequence":"additional","affiliation":[]},{"given":"Robert A","family":"Hauser","sequence":"additional","affiliation":[]},{"given":"David","family":"Houghton","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Hutchman","sequence":"additional","affiliation":[]},{"given":"Arnaldo","family":"Isa","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Juncos","sequence":"additional","affiliation":[]},{"given":"Sulada","family":"Kanchana","sequence":"additional","affiliation":[]},{"given":"Iryna","family":"Karaban","sequence":"additional","affiliation":[]},{"given":"Gabriela","family":"Klodowska-Duda","sequence":"additional","affiliation":[]},{"given":"Norbert","family":"Kovacs","sequence":"additional","affiliation":[]},{"given":"Dariusz","family":"Koziorowski","sequence":"additional","affiliation":[]},{"given":"Jaime","family":"Kulisevsky Bojarski","sequence":"additional","affiliation":[]},{"given":"Rajeev","family":"Kumar","sequence":"additional","affiliation":[]},{"given":"Kore","family":"Liow","sequence":"additional","affiliation":[]},{"given":"Vered","family":"Livneh","sequence":"additional","affiliation":[]},{"given":"Juan","family":"Lopez Lozano","sequence":"additional","affiliation":[]},{"given":"Lan","family":"Luo","sequence":"additional","affiliation":[]},{"given":"Nataliya","family":"Lytvynenko","sequence":"additional","affiliation":[]},{"given":"Irene","family":"Malaty","sequence":"additional","affiliation":[]},{"given":"Roberto","family":"Marconi","sequence":"additional","affiliation":[]},{"given":"Ana Raquel","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Irene","family":"Martinez Torres","sequence":"additional","affiliation":[]},{"given":"Aashoo","family":"Mentreddi","sequence":"additional","affiliation":[]},{"given":"Pablo","family":"Mir Rivera","sequence":"additional","affiliation":[]},{"given":"Francesca","family":"Morgante","sequence":"additional","affiliation":[]},{"given":"Sergii","family":"Moskovko","sequence":"additional","affiliation":[]},{"given":"Stephen","family":"Mullin","sequence":"additional","affiliation":[]},{"given":"Marshall","family":"Nash","sequence":"additional","affiliation":[]},{"given":"Yuliya","family":"Neryanova","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Onofrj","sequence":"additional","affiliation":[]},{"given":"Jill","family":"Ostrem","sequence":"additional","affiliation":[]},{"given":"Claudio","family":"Pacchetti","sequence":"additional","affiliation":[]},{"given":"Neepa","family":"Patel","sequence":"additional","affiliation":[]},{"given":"Nicola","family":"Pavese","sequence":"additional","affiliation":[]},{"given":"Clelia","family":"Pellicano","sequence":"additional","affiliation":[]},{"given":"Manuela","family":"Pilleri","sequence":"additional","affiliation":[]},{"given":"Dimitry","family":"Pokhabov","sequence":"additional","affiliation":[]},{"given":"Gonzalo","family":"Revuelta","sequence":"additional","affiliation":[]},{"given":"Ana Margarida","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Ramon","family":"Rodriguez","sequence":"additional","affiliation":[]},{"given":"Monika","family":"Rudzinska","sequence":"additional","affiliation":[]},{"given":"Nighat","family":"Sarwar","sequence":"additional","affiliation":[]},{"given":"Julie","family":"Schwartzbard","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Scorr","sequence":"additional","affiliation":[]},{"given":"Binit","family":"Shah","sequence":"additional","affiliation":[]},{"given":"Matej","family":"Skorvanek","sequence":"additional","affiliation":[]},{"given":"John","family":"Slevin","sequence":"additional","affiliation":[]},{"given":"Tatyana","family":"Slobodin","sequence":"additional","affiliation":[]},{"given":"Gianfranco","family":"Spalletta","sequence":"additional","affiliation":[]},{"given":"Alessandro","family":"Stefani","sequence":"additional","affiliation":[]},{"given":"Lynn","family":"Struck","sequence":"additional","affiliation":[]},{"given":"Michele","family":"Tagliati","sequence":"additional","affiliation":[]},{"given":"Yen","family":"Tai","sequence":"additional","affiliation":[]},{"given":"Danette","family":"Taylor","sequence":"additional","affiliation":[]},{"given":"Alessandro","family":"Tessitore","sequence":"additional","affiliation":[]},{"given":"Astrid","family":"Thomas","sequence":"additional","affiliation":[]},{"given":"Winona","family":"Tse","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Valkovic","sequence":"additional","affiliation":[]},{"given":"Leo","family":"Verhagen","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Vostrikova","sequence":"additional","affiliation":[]},{"given":"Benjamin","family":"Walter","sequence":"additional","affiliation":[]},{"given":"David","family":"Weisman","sequence":"additional","affiliation":[]},{"given":"Gilad","family":"Yahalom","sequence":"additional","affiliation":[]},{"given":"Zuleykha","family":"Zalyalova","sequence":"additional","affiliation":[]},{"given":"Katerina","family":"Zarubova","sequence":"additional","affiliation":[]},{"given":"Irina","family":"Zhukova","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(24)00052-8_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/mds.27216","article-title":"Levodopa: a new look at an old friend","volume":"33","author":"Olanow","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.parkreldis.2014.06.001","article-title":"Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries","volume":"20","author":"Hechtner","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12883-017-0904-4","article-title":"Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database","volume":"17","author":"McLean","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/mds.28599","article-title":"Translating evidence to advanced Parkinson's disease patients: a systematic review and meta-analysis","volume":"36","author":"Nijhuis","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib6","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.3233\/JPD-212650","article-title":"Bringing advanced therapies for Parkinson's disease to the clinic: the patient's perspective","volume":"11","author":"Mathur","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/S1474-4422(24)00052-8_bib7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1474-4422(22)00400-8","article-title":"Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial","volume":"21","author":"Soileau","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(06)70521-X","article-title":"Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications","volume":"5","author":"Olanow","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib9","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s00415-012-6798-6","article-title":"Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review","volume":"260","author":"Volkmann","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1036068","article-title":"The pharmacokinetics of continuous subcutaneous levodopa\/carbidopa infusion: findings from the ND0612 clinical development program","volume":"13","author":"LeWitt","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parkreldis.2021.09.024","article-title":"ND0612 (levodopa\/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: a randomized, placebo-controlled phase 2 study","volume":"91","author":"Giladi","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JPD-202285","article-title":"Continuous subcutaneous levodopa delivery for Parkinson's disease: a randomized study","volume":"11","author":"Olanow","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/S1474-4422(24)00052-8_bib13","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/mds.28758","article-title":"Subcutaneous levodopa infusion for Parkinson's disease: 1-year data from the open-label BeyoND study","volume":"36","author":"Poewe","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1474-4422(24)00052-8_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002826-200003000-00003","article-title":"A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia","volume":"23","author":"Hauser","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib16","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib17","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S1474-4422(24)00052-8_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for impulsive-compulsive disorders in Parkinson's disease-rating Scale","volume":"27","author":"Weintraub","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/S1474-4422(24)00052-8_bib21","article-title":"Minimal clinically important difference in Parkinson's disease as assessed in pivotal trials of pramipexole extended release","volume":"2014","author":"Hauser","year":"2014","journal-title":"Parkinsons Dis"},{"key":"10.1016\/S1474-4422(24)00052-8_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1474-4422(15)00336-1","article-title":"Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial","volume":"15","author":"Ferreira","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(05)71083-7","article-title":"Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial","volume":"365","author":"Rascol","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(24)00052-8_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1474-4422(13)70025-5","article-title":"Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial","volume":"12","author":"Hauser","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1212\/WNL.0b013e31822affdb","article-title":"Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial","volume":"77","author":"Schapira","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(24)00052-8_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","article-title":"Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study","volume":"13","author":"Olanow","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1474-4422(18)30239-4","article-title":"Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial","volume":"17","author":"Katzenschlager","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/S1474-4422(24)00052-8_bib28","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/mds.28703","article-title":"Levodopa-carbidopa intestinal gel reduces dyskinesia in Parkinson's disease in a randomized trial","volume":"36","author":"Freire-Alvarez","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mds.20276","article-title":"Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges","volume":"20","author":"Katzenschlager","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/S1474-4422(24)00052-8_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2408","article-title":"Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa\/carbidopa intestinal gel","volume":"11","author":"Pauls","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/S1474-4422(24)00052-8_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2147\/JPR.S334840","article-title":"Study design characteristics and endpoints for enriched enrollment randomized withdrawal trials for chronic pain patients: a systematic review","volume":"15","author":"Kopsky","year":"2022","journal-title":"J Pain Res"},{"key":"10.1016\/S1474-4422(24)00052-8_bib32","series-title":"Enrichment strategies for clinical trials to support determination of effectiveness of human drugs and biological products: guidance for industry","year":"2019"}],"updated-by":[{"DOI":"10.1016\/s1474-4422(24)00182-0","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442224000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442224000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:29:10Z","timestamp":1762547350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442224000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1474442224000528"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(24)00052-8","relation":{},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of continuous subcutaneous levodopa\u2013carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(24)00052-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(24)00116-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}